CD8A and pneumocystosis: If PCP could enhance the DC cross-presentation of exogenous OVA protein, the CD8+ T cells, which specifically recognize the SIINFEKL (MHC-class I-restricted) epitope of OVA will be primed and able to kill target cells pulsed with SIINFEKL peptide.